A 58-year-old male smoker presents with progressive dyspnea, chronic productive cough, and recurrent respiratory infections over 8 years. Clinical examination reveals barrel chest, pursed-lip breathing, and cyanosis. Spirometry shows FEV₁/FVC ratio of 0.62 with reduced FEV₁. Which investigation is most specific for differentiating emphysema from chronic bronchitis in this patient?

Explanation

## Investigation of Choice for Emphysema vs Chronic Bronchitis **Key Point:** HRCT chest is the gold standard imaging modality for distinguishing emphysema from chronic bronchitis based on structural lung parenchymal changes. ### Why HRCT is Superior HRCT provides: - **Centrilobular emphysema pattern** — characteristic of smoking-related emphysema (upper lobe and upper zone predominance) - **Panlobular emphysema pattern** — seen in alpha-1 antitrypsin deficiency (lower lobe predominance) - **Paraseptal emphysema** — peripheral/distal alveolar involvement - **Bronchial wall thickening and bronchiectasis** — features of chronic bronchitis - **Air trapping on expiratory images** — confirms small airway disease ### Pathological Correlation | Feature | Emphysema | Chronic Bronchitis | |---------|-----------|-------------------| | **Pathology** | Permanent alveolar destruction, loss of elastic recoil | Mucus hypersecretion, airway inflammation, bronchial wall thickening | | **HRCT Finding** | Decreased lung attenuation, lack of normal vascular tapering | Bronchial wall thickening, bronchus-to-artery ratio >1 | | **Distribution** | Upper lobes (smoking-related) or lower lobes (alpha-1 AT deficiency) | Diffuse, no lobar predominance | **High-Yield:** HRCT can identify the **predominant pathology** in mixed COPD and guide management (e.g., bronchodilators for emphysema, mucolytics for bronchitis). **Clinical Pearl:** Expiratory HRCT is essential — air trapping (areas of low attenuation on expiration) confirms emphysema and small airway disease. [cite:Harrison 21e Ch 297]